Trial
NCT04064684
Inhaled Steroids for the Treatment of Early Pediatric Acute Respiratory Distress Syndrome
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
The University of Texas Health Science Center, Houston
Collaborators
National Center for Advancing Translational Sciences (NCATS)
Condition
Acute Respiratory Distress Syndrome
Intervention
Budesonide
Why stopped
Enrollment difficulties after the start of the COVID-19 pandemic.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-13